Literature DB >> 30056148

Severe asthma with eosinophilic gastroenteritis effectively managed by mepolizumab and omalizumab.

Duhyun Han1, Jason K Lee2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30056148     DOI: 10.1016/j.anai.2018.07.030

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  3 in total

Review 1.  Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications.

Authors:  Carlo Maria Rossi; Marco Vincenzo Lenti; Stefania Merli; Amelia Licari; Martina Votto; Gian Luigi Marseglia; Antonio Di Sabatino
Journal:  Clin Transl Allergy       Date:  2022-05-23       Impact factor: 5.657

Review 2.  Eosinophilic Gastritis/Gastroenteritis.

Authors:  Phillip H Chen; Lorraine Anderson; Kuixing Zhang; Guy A Weiss
Journal:  Curr Gastroenterol Rep       Date:  2021-07-30

3.  Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report.

Authors:  C Caruso; S Colantuono; D Pugliese; C Di Mario; B Tolusso; E Gremese; G Papparella; F Castrì; A Gasbarrini; A Romano; A Armuzzi
Journal:  Allergy Asthma Clin Immunol       Date:  2020-04-22       Impact factor: 3.406

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.